Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2014-01-14

Clinical Trial Update: New Proteins in Body Fluids as Potential Biomarker for Alzheimer's Disease: a Pilot Study

View source ↗

Summary

This clinical trial update reports on a pilot study investigating new proteins in body fluids as potential biomarkers for late-onset Alzheimer's disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Universitaire Ziekenhuizen KU Leuven | Conditions: Alzheimer Disease, Late Onset | Status: UNKNOWN